文献速递妇科产科

卵巢癌一级预防:机会性输卵管切除术的患者决策辅助工具

Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
PubMed 文献 · Am J Obstet Gynecol · 2021-09-15

本研究基于国际患者决策辅助标准,与患者和医疗专业人员合作开发并测试了用于机会性输卵管切除术的患者决策辅助工具。该工具包含两条路径:附加于腹部手术的输卵管切除术和作为绝育方法的输卵管切除术,在线提供信息章节、知识测验、考虑陈述和个人偏好总结。患者测试评分为「优秀」,妇科医生测试评分为「良好」,并满足国际患者决策辅助标准49项适用条目中的45项。

要点

  • 机会性输卵管切除术可降低卵巢癌终身风险,但妇科医生和医院的建议存在差异。
  • 决策辅助工具包含两条路径:附加手术和绝育方法,提供解剖、风险降低及利弊信息。
  • 工具在线可用,患者测试评「优秀」,妇科医生评「良好」,满足45/49项标准。

核心结论

  • 开发了针对机会性输卵管切除术和作为绝育方法的输卵管切除术的患者决策辅助工具。
  • 患者和妇科医生均认为该工具是有用的,能支持患者做出知情决策并辅助咨询过程。

研究设计与样本

  • 遵循国际患者决策辅助标准进行系统开发,数据收集于2019年6月至2020年6月。
  • 采用定性和定量方法,与患者和医疗专业人员合作,由多学科指导小组监督,分4个阶段进行。

主要发现

  • 决策辅助工具应包含两条独立路径:一条为附加于腹部手术的输卵管切除术信息,另一条为作为绝育方法的输卵管切除术信息。
  • 两条路径均包含卵巢和输卵管解剖与功能、卵巢癌风险降低以及机会性输卵管切除术的潜在获益和风险信息。
  • 绝育路径还包含各种绝育方法及意外妊娠风险信息。
  • 工具为在线形式,包括信息章节、知识测验、考虑陈述和详细记录患者偏好与考虑的总结。
  • 经过第一轮α测试调整后,改进的工具在患者测试中评分为「优秀」,在妇科医生测试中评分为「良好」,并满足国际患者决策辅助标准49项适用条目中的45项。

关键数值与推荐

  • 患者测试评分为「优秀」,妇科医生测试评分为「良好」。
  • 满足国际患者决策辅助标准49项适用条目中的45项。

临床怎么用

  • 该决策辅助工具可用于接受盆腔妇科手术并希望保留卵巢或选择绝育的女性,支持机会性输卵管切除术的知情决策。
  • 工具可标准化咨询材料,减少妇科医生和医院之间的实践差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The discovery of the fallopian tube epithelium as the origin of high-grade serous ovarian cancer has brought a new option for ovarian cancer prevention. The fallopian tubes have no known function after completion of childbearing and can be removed to reduce the lifetime risk of ovarian cancer. Although the lifetime risk in the general population does not justify preventive surgery in itself, salpingectomy can be performed during abdominal surgery for other indications, also known as an opportunistic salpingectomy. The popularity of opportunistic salpingectomy is increasing worldwide; however, the variation between gynecologists and hospitals in their advice on opportunistic salpingectomy occurs because of the remaining uncertainty of evidence. Therefore, whether a woman can make her own decision depends on the hospital or gynecologist she visits. We aimed to lower this practice variation by providing standardized and unbiased counseling material. OBJECTIVE: We aimed to develop and test a patient decision aid for opportunistic salpingectomy in women undergoing pelvic gynecologic surgery to either retain the ovaries or opt for sterilization. STUDY DESIGN: We followed a systematic development process based on the International Patient Decision Aid Standards. Data were collected between June 2019 and June 2020, using both qualitative and quantitative methods. The development process that occurred in collaboration with patients and healthcare professionals was overseen by a multidisciplinary steering group and was divided into 4 phases: (1) assessment of decisional needs using individual telephone interviews and questionnaires; (2) development of content and format based on decisional needs, current literature, and guidelines; (3) alpha testing and the first revision round; and (4) alpha testing and the second revision round. RESULTS: An outline of the patient decision aid was developed on the basis of decisional needs, current literature, and guidelines. It became clear that the decision aid should consist of 2 separate paths: one with information specifically for salpingectomy in addition to abdominal surgery and one for salpingectomy as a sterilization method. Both paths contained information on the anatomy and function of ovaries and fallopian tubes, risk reduction of ovarian cancer, and potential benefits and risks of opportunistic salpingectomy. Moreover, the sterilization path contains information on various sterilization methods and risks of unwanted pregnancy. The patient decision aid was developed as an online tool that includes information chapters, a knowledge quiz, consideration statements, and a summary detailing the patient's preferences and considerations. Adjustments were made following alpha testing round 1. The improved patient decision aid was subjected to usability tests (alpha testing round 2), in which it scored an "excellent" in tests with patients and a "good" in tests with gynecologists. Furthermore, our patient decision aid met the requirements of 45 of 49 applicable items from the International Patient Decision Aid Standards criteria. CONCLUSION: In collaboration with patients and healthcare professionals, a patient decision aid was developed on opportunistic salpingectomy and salpingectomy as a sterilization method. Both patients and gynecologists believed it is a useful tool that supports patients in making an informed decision whether to undergo an opportunistic salpingectomy and supports the counseling process by gynecologists.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. van Lieshout LAM, Gelderblom ME, de Hullu JA, et al. Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy. Am J Obstet Gynecol. 2021. PMID: 34536392. doi:10.1016/j.ajog.2021.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。